Introduction
The Ras superfamily of GTP-binding proteins are membrane-anchored, intracellular signal transducers responsible for a wide variety of cellular functions. The Ras subfamily of G-proteins consists of nine evolutionary conserved genetic elements widely implicated in controlling cell growth and dierentiation (Lowy and Willumsen, 1993) . The prototypic ras oncogenes, which are comprised of H-, K-, and Nras, have been known to be oncogenically activated in a signi®cant fraction of human tumors (Bos, 1989) . RaplA (K-rev-1), together with RaplB, are ras-related molecules, with the former being shown to reverse the transformation caused by the K-ras oncogene (Kitayama et al., 1989) . RalA and its close relative, RalB, form a distinct subgroup, and recent evidence has suggested that RalA may be involved in v-srcinduced activation of phospholipase D (Jiang et al., 1995) . More recently, two additional members of the Ras subfamily, TC21, and R-ras, have been demonstrated to display transforming activity when oncogenically activated (Graham et al., 1994; Chan et al., 1994; Saez et al., 1994; Cox et al., 1994) . In the case of TC21, it has been shown to possess transforming activity comparable to that of ras oncogenes and mutations have been detected in human tumor samples Huang et al., 1995) . In contrast, Rras induced cellular transformation is weaker and the resulting foci are morphologically distinct (Saez et al., 1994; Cox et al., 1994) . Interestingly, R-ras has recently been shown to regulate cell adhesion by activating surface adhesion receptors, integrins (Zhang et al., 1996) . However, the relevance of cell adhesion in R-ras mediated cellular transformation has not been fully examined.
The prevailing mechanism of Ras transformation is characterized by a model which involves the participation of multiple downstream signaling cascades. Besides the ubiquitous Ras-Raf-MEK-MAPK pathway, numerous other signaling molecules have been shown to either directly interact with Ras or participate in its transforming signaling. These include phosphatidylinositol-3 kinase (PI3-K) (Rodriguez-Viciana et al., 1997) , Racl (Qiu et al., 1995a) , RhoA (Qiu et al., 1995b) , RhoB (Prendergast et al., 1995) , Cdc42 (Qiu et al., 1997) , RalGDS , and Pak (Tang et al., 1997) . Codons 32 ± 40 in Ras protein are important for its interaction with downstream effectors and constitute the eector-binding site (Lowy and Willumsen, 1993) . Site-speci®c mutations introduced into this domain have led to the generation of partialloss-of function mutants, in which the loss of speci®c biological properties is correlated with the loss of interaction with speci®c substrates (Rodriguez-Viciana et al., 1997; White et al., 1995; Joneson et al., 1996; Khosravi-Far et al., 1996) . Paradoxically, members of the Ras subfamily all encode an identical eectorbinding site and, therefore, would be expected to bind to common downstream eectors. This observation is in contrast with the highly diverse biological properties displayed by members of this subfamily.
Ras proteins also play a crucial role in conveying upstream receptor mediated signaling events (Lowy and Willumsen, 1993) . Various guanine nucleotide exchanger factors (GEF) have been isolated for the Ras subfamily members, such as SOS, GRF, GRF2, C3G, and RalGDS-related sequences (Quilliam et al., 1995) . SOS is known to stimulate the GTP exchange on Ras (Egan et al., 1993) , while GRF has been shown to activate both Ras (Farnsworth et al., 1995) and Rras GTP-loading (Gotoh et al., 1997) . Interestingly, C3G, which was ®rst isolated based on its ability to interact with Crk src-homology domain 3 (SH3) (Tanaka et al., 1994) , has recently been shown to possess exchange activity on both K-rev-1/RaplA (Gotoh et al., 1995) , and R-ras (Gotoh et al., 1997) . Finally, several members of a group of exchange factors, including RalGDS, Rgl, RglII, and Rlf, have been found to induce exchange activities preferentially on the Ral-related GTPases (Albright et al., 1993; Spaargaren and Bischo, 1994; Peterson et al., 1996; Wolthuis et al., 1996) . Interestingly, these RalGDS molecules possess in their C-terminal end, conserved domains which mediate the binding to the GTP-, but not the GDP-bound forms of Ras. This observation raises the possibility that RalGDS-related molecules are in fact downstream eectors of Ras and play a role in Ras-mediated transforming signaling events (Urano et al., 1996) .
The tremendous complexity of the intracellular signaling network would predict the existence of a diverse repertoire of signaling molecules in regulating these intricate events. In this study, we report the identi®cation of a human cDNA sequence which shows considerable homology to the transforming oncogenes of the Ras subfamily. The distinct biological properties displayed by this novel ras-related gene and its unique pattern of tissue distribution may de®ne a whole new class of G-proteins with an as of yet unidenti®ed biological function.
Results

Cloning of a human R-ras3 cDNA
In an eort to identify additional novel human sequences closely related to either TC21 (R-ras2) or R-ras oncogenes, we have performed Genebank database search using the full-length TC21 (Drivas et al., 1990) and R-ras (Lowe et al., 1987) cDNA sequences as templates. We have identi®ed a previously unpublished rat cDNA sequence (accession number ± D89863), which showed considerable sequence similarity to the human TC21 gene. Using the rat cDNA sequence to further search in the Expression Sequence Tag (EST) database, two human EST cDNA clones (accession numbers ± AA324154 and W44458) were uncovered which displayed signi®cant sequence identity to the 5' and 3' coding regions of the rat sequence, respectively. PCR primers were then generated in regions of the human EST sequences which represent the translational start and termination regions of the TC21-related gene. Using DNA prepared from a human embryonic lung ®broblast cDNA library as template, we ampli®ed a DNA fragment of *630 basepairs (bp) in size and the PCR products were subsequently cloned into an eukaryotic expression vector, pCEV29. Nucleo- Figure 1 Sequence analysis of human R-ras3. (a) The nucleotide sequence of R-ras3 and the predicted amino acid sequence are depicted. The 209 amino acid R-ras encoded protein contains functional domains that are found in other ras-related GTPases, including the eector-binding site (underlined), and the consensus sequence in the C-terminus for membrane-localization (CVIL, italicized). (b) Amino acid sequence alignment of R-ras3 with the human (HU) Ras subfamily members and known ras-related sequences in C. elegans (CE). Only the N-terminal 117-amino acid catalytic domain (codon 14 ± 132) of R-ras3 was used in the alignment study. Residues with complete sequence identity are boxed and conserved amino acids are shaded. (c) Evolutionary tree of ras-related sequences was constructed based on the sequence alignment result generated in panel (b) . Numbers represent the levels of sequence identity between the indicated two groups of GTPases. All computer-assisted sequence analyses were performed using GeneWork software. Accession numbers for sequences used in these analyses are:
tide sequence analysis of the ampli®ed cDNA revealed an open reading frame of 627 bp, encoding for a molecule of 209-amino acids with a predicted relative molecular mass (*M r ) of 23.8 kilodaltons (kDa) (Figure 1a) . In vitro translation of the cloned cDNA in rabbit reticulocyte lysates has revealed a protein species of M r 27 kDa in size (Figure 2a) . The cloned cDNA was also fused in the N-terminus to a hemagglutinin (HA)-epitope, and transient transfection of this construct in COS7 cells has led to the expression of a readily detectable *30 kDa protein species (Figure 2b ). Since this novel sequence showed the highest sequence similarity among mammalian genes to TC21 (R-ras2), we therefore designated this human cDNA, R-ras3, to re¯ect the potential expanding family of ras-related G-proteins with R-ras being the ®rst identi®ed member (Lowe et al., 1987) .
Amino acid sequence alignment has revealed signi®cant protein sequence similarity between R-ras3 and members of the mammalian Ras family of GTPases. R-ras3 shares with TC21 the overall secondary structure in possessing an N-terminal extension of 10 amino acids which were not present in the prototypic ras oncogenes (Figure 1a ). The Nterminal 117-amino acid catalytic domain of Ras has been shown to be important for its GTPase activity as well as in interacting with a host of downstream eectors (Lowy and Willumsen et al., 1993) . In this region, human R-ras3 was most related to TC21, displaying 75% sequence identity, which was followed by R-ras (65%) and H-ras (63%) (Figure 1b) . Similarity between R-ras3 and other ras-related Gproteins decreased dramatically in the C-terminal divergent region, resulting in an average of only *30% sequence identity. Moreover, the R-ras3 Cterminal sequence (CVIL) would predict the encoded protein to be post-translationally modi®ed by the prenylation enzyme, geranyl-geranyl transferase I (Der and Cox, 1991) .
Interestingly, sequences homologous to the human R-ras3 gene were not only restricted to the vertebrate system. A recently identi®ed Caenorhabditis elegans rasrelated sequence, ras2 (accession number U80675), also showed signi®cant sequence similarity to R-ras3 in the N-terminal catalytic domain (Figure 1b and c) . In contrast, the two additional C. elegans ras-related sequences, let-60 (Han and Sternberg, 1990 ) and R-ras1 (accession number U56930) are closer to mammalian Ras and R-ras/TC21 genes, respectively (Figure 1b and c).
Transformation of NIH3T3 cells by R-ras3
We have previously reported the expression cloning of an activated TC21 gene from a human ovarian carcinoma cell line, A2780 . The glutamine (CAA) to leucine (CTA) mutation in codon 72 (position 61 in human H-ras) of the TC21 gene found in this tumor line confers striking transforming activity to the TC21 proto-oncogenic sequence. The close similarity between R-ras3 and TC21 raises the possibility that these ras-related molecules may have evolutionary conserved biological properties. To examine if R-ras3 also possesses transforming activity, the corresponding glutamine (CAG) to leucine (CTG) mutation was introduced in codon 71 of the Rras3 coding sequence. The resulting mutant, R-ras3 L71, would be expected to be GTPase-de®cient, and constitutively active.
Variable amounts of R-ras3 L71 mutant were then introduced into NIH3T3 cells and parallel cultures were transfected with similar amounts of the oncogenic Ras (H-ras R12), TC21, (TC21 L72), and R-ras (R-ras L87) cDNAs in order to assess their relative transforming activities. As shown in Figure 3 , whereas transfection of wild-type R-ras3 did not result in any detectable transformed phenotypes, the constitutively active R-ras3 L71 mutant displayed readily detectable transformed foci, producing approximately *400 foci per pmole of DNA. In addition, R-ras3 transformed foci were reminiscent of the highly refractile, spindleshaped morphology as observed in both H-ras-or TC21-transformed cells ( Figure 3a) .
Next, we sought to determine the ability of R-ras3-transformed cells in proliferating in an anchorageindependent manner. For this, marker-selected NIH3T3 cells transformed by H-ras, TC21, R-ras or R-ras3 mutants were suspended in semi-solid agarose medium and continuously proliferating colonies were scored after 2 weeks in cultures. As shown in Figure 3 , in contrast to its weak focus forming activity, R-ras3-transformed NIH3T3 cells were able to proliferate at a signi®cantly higher frequency when compared with control cultures resulting in colonies exceeding 0.5 mm (4100 cells) in size ( Figure 3c ). In addition, R-ras3-induced cellular transformation was associated with an increased ability to proliferate under low-serum conditions when compared with control cells (data not shown). We conclude from these data that R-ras3 represents a new transforming member of the Ras gene family with a readily detectable ability in inducing both morphological transformation and anchorage-independent growth.
Perturbation of the MAPK pathway by R-ras3
The observed quantitative and qualitative dierences between R-ras3 and other Ras family members in The wild-type and L71 activated mutant of R-ras3 in the expression vector, pCEV29, were in vitro translated in rabbit reticulocyte lysates, and the *27 kDa protein species synthesized are indicated. The R-ras3 L71 encoded product displayed a faster mobility than the wild-type version which may due to conformational dierences and has been previously reported for Ras L61 mutant (Reynolds et al., 1987) .
(b) R-ras3 wild-type cDNA was tagged in the N-terminus by a hemagglutinin (HA) epitope, and was transiently transfected into COS7 cells. Following immunoprecipitation and Western blot analysis using an anti-HA antibody, the HA-R-ras3 fusion product was detected as a *30 kDa protein species. Ig: immunoglobulin inducing cellular transformation may re¯ect the potential divergence of R-ras3 in its downstream signaling events. The ubiquitous Ras-Raf-MEK-MAPK signaling cascade has been widely implicated as one of the major pathways in mediating ras transformation in NIH3T3 cells (Cowley et al., 1994) . To address whether the observed transforming activity of R-ras3 was correlated with its ability to activate the MAPK signaling cascade, we sought to investigate the relative ecacy of various ras-related oncogenes in stimulating MAPK activity. For this, transient transfection experiments were performed in NIH3T3 cells using expression plasmids representing the oncogenic mutants of H-ras, TC21, R-ras, and Rras3, together with a hemagglutinin (HA)-tagged MAPK (HA-erk2) cDNA construct. As shown in Figure 4a , H-ras R12 mutant induced ecient MAPK activation (*21.0-fold), which was followed by TC21 (*8.0-fold), and R-ras (*2.5-fold). In contrast, expression of R-ras3 in NIH3T3 cells only resulted in a modest but reproducible 2.0-fold increase in MAPK activity. These results strongly suggested that the low transforming activity displayed by R-ras3 was correlated with its weak intrinsic ability to stimulate the MAPK pathway. A potential explanation for this observation could be that R-ras3 has dierential eects on Ras downstream eectors. One likely candidate would be p74 Raf, which upon the activation of p21 Ras, stimulates the sequential phosphorylations of a downstream kinase cascade leading to the ultimate activation of the MAPK activity. To examine if overexpression of Raf could potentiate the ability of R-ras3 to induce MAPK activity, transient transfection experiments were per-
Figure 4 Activation of MAPK pathway by R-ras3. (a) The relative ability of R-ras3 and various ras-related genes in activating the MAPK activity was measured by transient transfection assays in NIH3T3 cells. In addition, the ability of c-raf-1 in cooperating with Ras and R-ras3 in activating MAPK was also examined (b). The amount of each expression plasmid used is parenthesized. Results represent fold stimulation with standard deviations (error bars) derived from triplicate plates of a typical experiment which has been repeated twice with very similar results being obtained. (c) The cooperative transformation of NIH3T3 cells by R-ras3 L71 mutant and wild-type c-raf-1 is shown. Note the striking increase in the size of R-ras3 transformed foci when co-transfected with the c-raf-1 plasmid. Similar results were also obtained when R-ras3 L71 was co-transfected with H-ras R12. The results are summarized (right panel) showing the *3 ± 4-fold increase in focus forming units when R-ras3 was co-transfected with components of the MAPK signaling pathway. Data represent averaged values from duplicate plates of a typical focus forming assay which has been repeated in 3 independent experiments formed by introducing either R-ras3 L71 mutant alone or co-transfected with a c-raf-1 plasmid in NIH3T3 cells. As positive control, we have reduced the amount of H-ras R12 mutant (0.3 mg) in order to produce a modest increase (*3.0-fold) in MAPK activity. As shown in Figure 4b , co-transfection of H-ras R12 with c-raf-1 resulted in an enhancement of the MAPK activity by *15.0-fold. Similarly, R-ras3 L71 also displayed a similar cooperative eect with c-raf-1 producing in this case, a *10.0-fold increase in the MAPK activity.
To examine if the synergistic eect observed between R-ras3 and Raf in stimulating MAPK would lead to a similar cooperative eect in cellular transformation, we co-transfected expression constructs of R-ras3 activated mutant and c-raf-1 in NIH3T3 cells. As shown in Figure 4c , whereas c-raf-1 expression plasmid alone did not result in the formation of transformed foci, cotransfection with R-ras3 L71 enhanced the number of transforming foci by *4.0-fold. More importantly, the resulting foci were strikingly larger in size and appeared much earlier than when they were transfected separately. Similarly, co-transfection of R-ras3 with a low level of H-ras R12 mutant also resulted in a cooperative eect under similar experimental conditions (Figure 4d) . We conclude from all these experiments that R-ras3 possesses a weak intrinsic ability to induce MAPK activity, and its ability to cooperate with c-raf-1 in stimulating the MAPK pathway was correlated with their synergistic eect in cellular transformation.
Interactions of R-ras3 with Ras downstream eectors
To further explore the synergistic eect of R-ras3 and Raf, we sought to compare the binding capacity of Ras or R-ras3 with Raf utilizing the yeast two-hybrid system. Since both Ras and TC21 have been shown to interact with additional common substrates, such as RalGDS and RglII (Spaargaren and Bischo, 1994; Peterson et al., 1996) , we therefore, included these molecules in our interaction analysis.
To facilitate the detection of potential subtle interactions between R-ras3 and test eectors, we have created a R-ras3 bait which lacked the Cterminal membrane-anchoring signal sequence, CVIL, in order to optimize targeting to the yeast nuclear compartment. As a positive control, a similar construct was generated with a H-ras cDNA which has been shown to mediate strong binding to the eectors being examined (Van Aelst et al., 1993) . Since conserved regions referred to as the Ras-Binding Domains (RBD) have been delineated within the Raf, RalGDS, and RglII coding sequences, we PCR-ampli®ed these regions and subcloned these fragments into the yeast expression vector, pJG4-5. As shown in Figure 5 , binding of Ras to Raf, RalGDS and RglII was clearly demonstrated by the stimulation of transcriptional activity from the lacZ reporter gene, which was manifested by the intense blue color of yeast colonies grown on X-gal containing plates. In contrast, R-ras3 displayed a considerably dierent pattern of interactions, with its binding to Raf and RalGDS being substantially less than that of Ras, and no detectable interaction was observed with RglII. We speculate from these results that the observed weaker transforming activity of R-ras3 and the lower intrinsic ability to activate MAPK may be explained by its weak interaction with Raf.
Eects of R-ras3 on transcriptional responses
To further characterize the observed dierences between R-ras3 and other Ras family members, we sought to determine if R-ras3 could preferentially activate nuclear transcription events from dierent promoter elements previously known to be transactivated by Ras (Galang et al., 1994) . For this, response elements representing the binding sites for dierent transcription factors, including SRF, ETS/ TCF, Fos/Jun, and NF-kB/Rel, were constructed (Li et al., 1996) . To assess if R-ras3 could promote nuclear gene expression events, transient transcription reporter assays were performed in NIH3T3 cells. Following lysis of transfected cultures, the extent of gene transcription was quantitated by measuring the levels of transcriptional activity generated from the luciferase reporter gene, using b-luciferin as the substrate.
As shown in Figure 6 , mutant forms of H-ras, TC21, R-ras and R-ras3 activated transcription from dierent response elements with potency generally re¯ecting their relative ability in transforming NIH3T3 cells. However, whereas R-ras3 stimulated transcriptional responses by *2.0-fold for ETS and NF-kB response elements, no signi®cant stimulation of transcription was observed with SRF and TRE reporter constructs.
Tissue Distribution of R-ras3
Transforming oncogenes of the Ras subfamily, including Ras, TC21 or R-ras, all displayed a broad tissue expression pattern, which may re¯ect their vital role in multiple cell types Saez et al., 1994) . To examine whether R-ras3 has a similar pattern of tissue distribution, we performed Northern blot analysis using total RNAs derived from various human tissue origins. Using a 32 P-labeled R-ras3 full-length cDNA as probe, we observed a * 3.8 kb transcript expressed at high levels in both the brain and heart (Figure 7) . RgIII RBD Figure 5 Interaction of R-ras3 with Ras eectors. The wild-type versions of both H-ras and R-ras3 were used in the yeast twohybrid interaction tests based on the LexA transcription factor system, and the readout was provided by the LexA operon-lacZ reporter plasmid, pSH18-34.`Bait' plasmids were co-transformed into yeast strain, EGY48, with interaction partners (`prey') representing the Ras-Binding Domains (RBDs) of Raf, RalGDS, and RglII. Next, two randomly selected co-transformants of each interaction test were then patched directly onto agar plates containing X-gal and the extent of blue color developed was recorded. In all cases, bait or prey plasmids when co-transformed with control plasmids, pJG4-5 and pEG202, respectively, did not result in any signi®cant interactions Similar size transcripts were not, however, detected in other tissues being examined. This strikingly restricted pattern of expression was in contrast with those previously reported for Ras, TC21, or R-ras, and would suggest a speci®c role of R-ras3 in these tissues.
Discussion
Cellular responses to external stimuli in multicellular organisms are mediated by a diverse and complex intracellular signaling network for the control of regulated gene expression (Hunter, 1997) . The present report describes the identi®cation of R-ras3 as an additional member of the Ras gene family. The gene product encoded by the human R-ras3 is closely related to a C. elegans ras-related gene, ras2. Interestingly, the diversity of ras-related sequences in the mammalian system is clearly mirrored by the nonvertebrate organisms, since the human Ras and R-ras genes are closely related to the C. elegans let-60, and R-ras1 genes, respectively. The high levels of evolutionary conservation among ras-related sequences would argue against these molecules representing redundant ras sequences. Rather, various rasrelated genes may play a major role in regulating vital cellular functions found throughout evolution.
Among mammalian genes, although R-ras3 is more closely related to TC21 than to Ras or R-ras, protein sequence alignment studies suggest that R-ras3 constitutes an evolutionarily distinct class of Gproteins. This is supported by the observation that in the N-terminal catalytic domain of Ras GTPases, cysteine residues among H-, K-and N-ras, or between TC21 and R-ras are highly conserved. In contrast, Rras3 is completely devoid of cysteine residues suggesting that it may attain an unique tertiary conformation and thereby could display distinct biochemical properties.
R-ras3 constitutes the sixth member of the Ras gene family to possess readily detectable transforming properties. However, the eciency of R-ras3 in inducing transformation is less than that of Ras, TC21, and R-ras. Interestingly, the hierarchy of transforming activity elicited by these ras-related genes shows a general correlation with their relative ability to stimulate the MAPK pathway. Consistent with these ®ndings, R-ras3, also displays a substantially weaker interaction with Raf and has only modest eects on trans-activation from dierent transcription response elements. Our observations that wild-type Raf synergizes dramatically with R-ras3 in both cellular transformation and MAPK activation, raises the possibility that Raf may be a rate-limiting step in Rras3 mediated transforming processes. However, whether R-ras3 binds and activates Raf in vivo or that the observed synergistic eect is due to other mechanisms remains to be determined.
Ras has also been shown to activate several other signaling cascades known to be critical for its , 1997; Qiu et al., 1995a Qiu et al., , b, 1997 Prendergast et al., 1995; Qiu et al., 1997; White et al., 1996; Tang et al., 1997) . We have performed preliminary tests of the ability of Rras3 to activate the c-Jun N-terminal kinase (JNK) cascade, but failed to detect a signi®cant perturbation of this particular pathway (data not shown). Given the fact that R-ras3 only interacts modestly with Raf and RalGDS, we speculate that R-ras3 induced biological eects may be coupled to a completely novel downstream signaling cascade. In this case, an eort to search for novel R-ras3 interacting proteins would be highly warranted.
The region encompassing residues 32 ± 40 (switch I) of Ras is important for its interactions with downstream substrates (Lowy and Willumsen, 1993) . More recently, the switch II domain of Ras (codons 59 ± 76), was also shown to be crucial in interacting with Raf (Drugan et al., 1996) , and R-ras3 shares 17 out of 18 amino acids in this domain. In addition, the regions immediately¯anking the switch I eector loop have been reported to play a role in Ras functions. For example, in regions¯anking the K-rev-1 eector loop, replacement of residues G26, I27, E30, K31, and E45, in K-rev-1 to those of Ras (N26, H27, D30 E31, V45) have been shown to confer Ras functions to K-rev-1 (Marshall et al., 1991) . Interestingly, the corresponding residues in R-ras3 (K36, I37, P40, D41, E55) are totally distinct from those of Ras, but share in two of these residues (I37 and E55) with K-rev-1 instead. These observations, once again, reinforce our earlier prediction that R-ras3 may interact with a repertoire of eectors quite dierent from those described for Ras.
The carboxyl-terminal half of Ras constitutes the highly divergent region which has been considered as dispensable for Ras functions (Lowy and Willumsen, 1993) . However, more recent ®ndings indicate that sequences in this region could modulate Ras functions. For example, mutations introduced into the polybasic lysine residues in C-terminal region of K-ras4B have been shown to reduce the transforming activity and membrane-binding properties of this oncogene (Jackson et al., 1994) . Incidentally, R-ras3 possesses ®ve lysine residues in the corresponding region, however, whether this polybasic domain plays a role in its biological functions is not known. Of note, we have also identi®ed a tripeptide sequence, RGD, located immediately downstream of the polylysine domain, which resembles the consensus binding site for the extracellular matrix protein, ®bronectin . Whether this sequence is fortuitously present in R-ras3 or it mediates interaction with novel molecules is not clear.
The restricted nature of R-ras3 gene expression in human brain and heart is intriguing. Obviously, the prospect of R-ras3 in regulating nerve signal transmission or muscle cell functions would be exciting areas for future studies. Of note, several Ras regulators and eectors have been shown to be expressed predominantly in the brain. These include Ras guanine nucleotide exchange factors ± GRF (Farnsworth et al., 1995) , and GRF2 (Fam et al., 1997) ; GTPase activating proteins ± NF1 (Hattori et al., 1992) and p98 R-ras GAP (Yamamoto et al., 1995) ; and a downstream eector ± B-raf (Vossler et al., 1997) . It is, therefore, of great interest to test the ability of these Ras regulators in interacting functionally with R-ras3.
Taking all these ®ndings together, we have provided evidence that R-ras3 possesses an intrinsic property of promoting cell growth. Given the distinct tissue expression pattern of R-ras3, it is plausible that Rras3 may serve as an important signal transducer for as of yet novel upstream stimuli in controlling cell proliferation.
Materials and methods
Cell lines
The NIH3T3 cell line, established in this laboratory was maintained in Dulbecco's Modi®ed Eagle's Medium (DMEM) supplemented with 10% calf serum (CS). NIH3T3 cells carrying dierent plasmid constructs were derived by transfecting 1.5610 5 cells with 1.0 mg of DNA by the standard calcium phosphate precipitation method (Wigler et al., 1977) . Transfectants were selected in Geneticin (750 mg/ml) and were passaged once prior to characterization of growth properties in vitro.
NIH3T3 focus forming assay
Approximately 1.5610 5 NIH3T3 cells were plated onto a 100 mm culture dish and DNA transfection was performed by the standard calcium phosphate precipitation method. In all cases, the amount of DNA added was normalized by the addition of a control expression vector, pCEV29. After transfection, cells were medium changed twice a week with 5% CS in DMEM and the number and quality of foci were scored every week for up to three weeks. All plates were then ®xed in 70% cold methanol and stained with Giemsa solution for detailed quantitative analysis.
Plasmids
Expression plasmids representing the oncogenic mutants of H-ras (H-ras R12), TC21 (TC21 L72), and R-ras (R-ras L87) were all cloned into an eukaryotic expression vector, pCEV29 . The full-length wild-type craf-1 construct was in the expression vector, pZIPneo (Saez et al., 1994) . pCEV29-HA-R-ras3 wt was constructed by cloning a BamHI ± BstEII restriction fragment containing the entire full-length R-ras3 cDNA into the expression vector, pCEV29-HA, which contains a hemagglutinin (HA) epitope.
Cloning and Site-directed mutagenesis
The human wild-type R-ras3 coding region (nucleotide 1 ± 627) was generated by polymerase chain reaction (PCR) method from a human embryonic lung ®broblast cDNA library (Rubin et al., 1991) with a BamHI-tagged (+) primer (5'-AAAGGATCCATGGCGACCAGCGCCGTCC CCAGT-3') and an EcoRI ± XhoI-tagged (7) primer (5'-TTTGAATTCCTCGAGTCACAAGATCACACATTGCA GTTTGTG-3'). PCR ampli®ed product was subcloned into the multiple cloning site of pCEV29, and was then subjected to sequencing analysis to con®rm authenticity. The R-ras3 L71 mutant was generated from the wild-type construct using a mutant oligonucleotide (5'-GCTgaat tcCTCCAGCCCAGCTGTGTC-3') encompassing an internal EcoRI site (small letter) for PCR ampli®cation with the BamHI-containing 5' primer at the translational start site. The resulting ampli®ed product was digested with BamHI and EcoRI and was used to replace the corresponding wildtype restriction fragment resulting in the generation of the CAG to CTG mutation (above, underlined) in codon 71 of R-ras3. The authenticity of all constructs described in this study have been con®rmed by nucleotide sequencing analysis.
In vitro transcription/translation
An in vitro transcription/translation kit was purchased from a commercial source (Promega, WI) . Approximately 250 ng of circular plasmid was added to the rabbit reticulocyte lysate in the presence of 10 mCi of [ 35 S]methionine (NEN, Dupont, 10 mCi/ml; speci®c activity, 1078 Ci/mmol) and Sp6 RNA polymerase in a ®nal volume of 10 ml. Reaction mixtures were incubated at 308C for 90 min. Samples (5 ml) were then boiled in Lammili loading buer and protein products were resolved by 14% polyacrylamide gel electrophoresis (SDS ± PAGE). Gels were then ®xed, treated with enhancer solution, dried and exposed to X-ray ®lms at 7708C for 1 ± 2 h.
Cell proliferation assays
For analysis of proliferation in semi-solid medium, 1610 3 , 1610 4 and 1610 5 cells were suspended in 0.5% agarose (Noble agar, Difco) in 10% CS as described elsewhere (DiFiore et al., 1987) . Colonies were stained and scored after 2 weeks. For low serum proliferation, approximately 10 3 cells were plated onto 60 mm ®bronectin (10 mg/ml, UBI, MA)-coated plates in the presence of full serum (10% CS). Twenty-four hours after plating, medium was changed to 10%, 2% and 0.5% and incubated for 2 weeks. Continuously proliferating colonies were then visualized by ®xation in 70% methanol and staining with Giemsa solution.
MAPK kinase assay
For transient assays, 1610 6 NIH3T3 cells were transfected singly or doubly by calcium phosphate precipitation method with the appropriate amount of each plasmid. The MAPK/erk2 was exogenously introduced by transfecting 3.0 mg of an HA-epitope-tagged MAPK/erk2 expression plasmid (Coso et al., 1995) . One day after transfection, cells were placed in serum-depleted medium for 16 h and then lysed in 600 ml of 25 mM HEPES (pH 7.5), 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1% Triton-X100, 0.5 mM DTT, 20 mM b-glycerophosphate, 0.1 mM Na 3 VO 4 , 2 mg/ml leupeptin, 100 mg/ml PMSF, 0.1%SDS, and 0.5% sodium deoxycholate. Exogenously expressed HA-MAPK/erk2 was immunoprecipitated from total cell lysates with 1.0 mg of an anti-HA monoclonal antibody (Monoclonal Core Facility, The Mount Sinai School of Medicine), followed by coupling to 30 ml of gbind G-sepharose (Pharmacia, NJ). Immune complexes were washed three times with 1% NP-40 and 2 mM Na 3 VO 4 in phosphate-buered saline (PBS), followed by one wash in 0.5 mM LiCl and 100 mM Tris (pH 7.5). Beads were then resuspended in 30 ml of a kinase reaction buer containing 12.5 mM HEPES pH 7.5, 12.5 mM b-glycerophosphate, 7.5 mM MgCl 2 , 0.5 mM EGTA, 0.5 mM NaF, 0.5 mM Na 3 VO 4 , 1.0 mCi of [ g32 P]ATP, 20 mM cold ATP, 3.3 mM DTT, and 60 mg of myelin basic protein (Sigma, MO) and incubated at 308C for 30 min. Equal aliquots (8 ml) of the reaction mix were spotted in duplicate onto cellulose ®lters (Life Tech., MD) and washed three times in ice cold 1.0 % o-phosphoric acid. Filters were then dried and counted in a scintillation counter.
ImmunoprecõÂ pitation and Western blotting analysis
Transiently transfected COS7 cells were lysed in 600 ml NP-40 solubilizer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 5 mM EDTA, and 1% NP-40) to obtain crude cell lysates. To detect HA-R-ras3 protein, an anti-HA monoclonal antibody (2.0 mg/ml) was added to the total cell lysates and incubated for 1 h at 48C. Antibodies were then absorbed onto 30 ml of g-bind G sepharose beads (Pharmacia, NJ) for an additional 30 min at 48C. Immunocomplexes were then washed three times with lysis buer and bound proteins were eluted by boiling in Lammili buer and resolved on a 14% SDS ± PAGE gel. Following transfer onto Immobilon-P membrane (Millipore, MA), HA-R-ras3 protein was detected by the sequential incubation with the same anti-HA antibody (1.5 mg/ml), a rabbit anti-mouse secondary antibody (1:2500 dilution, Jackson Lab, PA), and 25 I-labeled protein A (1:5000 dilution, ICN, CA).
Yeast two-hybrid interaction test
H-ras and X-ras3 wild-type cDNAs lacking the C-terminal membrane targeting sequences were subcloned into the yeast`bait' vector, pEG202, which contains the LexA DNA-binding domain. The Ras-Binding Domains (RBD) of human Raf (aa 48 ± 176), mouse RalGDS (aa 727 ± 853), and human RglII (aa 370 ± 518) were generated by PCR ampli®cation from cDNA plasmids and were subcloned into the yeast`prey' vector, pJG4-5, which contains the LexA trans-activation domain (Golemis et al., 1997) . Following co-transformation of the indicated interacting partners together with the lacZ reporter plasmid, pSH18-34, in the yeast strain, EGY48, transformants were selected on nutrient plates lacking the amino acids uracil, histidine and tryptophan. The extent of interactions between R-ras3 and candidate eectors were investigated by streaking individual yeast colony onto X-gal (80 mg/ml)-containing plates, which measure the levels of expression from the reporter gene, lacZ.
Transcription reporter assay
With the exception of ETS response element which consists of a single copy of an inverted repeat of the ETS binding site in the polyoma enhancer, all the reporter constructs were synthesized with oligonucleotide adaptors incorporating 3 tandemly positioned response elements: ETS: [GCTAGC(GCAGGAAGT ATACTTCCTGC) 1 These oligonucleotides were then inserted into the NheI and BglII sites of a backbone reporter vector, pGL-2 (Promega) with a c-fos minimal promoter and a downstream reporter gene, luciferase (Li et al., 1996) . Transient transfection of NIH3T3 cells was carried out in triplicate with 5610 5 cells per 60 mm culture dish using 3.0 mg of the reporter plasmid, and 3.0 mg of each expression vector. Twelve hours after transfection, cultures were maintained in low serum (0.5% CS) for 24 h. Cells were solubilized in 250 ml of reporter lysis buer (Promega, WI) and 25 ml of this extract was added to 80 ml of the luciferase substrate, bluciferin (Promega, WI); emitted light was then measured using a luminometer (Turner, CA). The data were normalized for the amount of protein and expressed as an arbitrary luminescence unit per mg of total protein. Also, we have tested for background transcription responses from the backbone vector which contains the c-fos minimal promoter but without the response elements, and did not observe any signi®cant trans-activation by Ras.
Northern analysis
A tissue RNA blot was purchased from a commercial source (Invitrogen, CA). The ®lter was hybridized at 428C
Characterization of a new ras-related gene A Kimmelman et al for 12 h with [ 32 P]-labeled DNA probes in 40% formamide, 56 saline sodium citrate (SSC), 56 Denhardt's solution, 1% SDS, and sonicated salmon sperm DNA (100 mg/ml). After the hybridization reactions, the ®lter was washed twice in 16 SSC and 0.1% SDS at room temperature and in 0.16 SSC and 0.1% SDS at 508C. The ®lter was dried and exposed to X-ray ®lms at 7708C for 2 days.
